Table 3.

Change in FGF21 levels over 8 weeks by treatment group by Stage 1 treatment.

Source	Numerator DF	Denominator DF	F-value	p-Value
Time	2	299	0.82	0.4411
Treatment group	1	187	0.07	0.7978
Time × treatment group	2	300	0.49	0.6116
HAMD-17 at Baseline	1	187	0.76	0.3833
Age at evaluation	1	179	12.75	0.0005
Sex	1	187	0.29	0.5880
Race	2	187	2.70	0.0698
Hispanic ethnicity	1	181	1.17	0.2800
Site	3	198	1.11	0.3456
BMI	1	189	3.48	0.0637